MNKD Q1 2022 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$813M

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$12M-31.2% YoY

Gross Profit

$994,0008.3% margin

Operating Income

-$21M-177.3% margin

Net Income

-$26M-216.8% margin

EPS (Diluted)

$-0.12

QoQ Revenue Growth

-4.2%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$23M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$308M

Total Liabilities

$540M

Stockholders' Equity

-$232M

Cash & Equivalents

$67M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$17M	-31.2%
Gross Profit	$994,000	$10M	-89.9%
Operating Income	-$21M	-$6M	-243.3%
Net Income	-$26M	-$13M	-101.3%

Revenue Segments

Product

$10M53%

License And Service

$9M47%